Αποτελέσματα Αναζήτησης
According to the United States National Library of Medicine, prostate cancer is the most common malignancy among elderly men and is the second leading malignancy in the Western world. Prostate cancer diagnoses are becoming more frequent, thanks largely to longer lifespans and improved screening methods.
Prostate cancer is a significant public health burden and a major cause of morbidity and mortality among men worldwide. Analyzing geographic patterns and temporal trends may help identify high-risk populations, suggest the degree of PSA testing, and provide clues to etiology.
Worldwide prostate cancer is the second most frequently diagnosed cancer and the fifth leading cause of cancer death among men, with an estimated 1.1 million new cases diagnosed and 307,000 deaths in 2012 1. Patterns and trends in prostate cancer incidence have been influenced by screening, diagnostic ascertainment, and population risk factors ...
Prostate cancer rates. The following table shows total global prostate cancer incidence and rates in 2022 for men. France, Guadeloupe had the highest overall rate of prostate cancer in 2022, followed by Lithuania.
4 Απρ 2024 · Prostate cancer is the most common cancer in men in 112 countries, and accounts for 15% of cancers. In this Commission, we report projections of prostate cancer cases in 2040 on the basis of data for demographic changes worldwide and rising life expectancy.
1 Ιαν 2020 · Prostate cancer incidence rates during the most recent 5 yr declined (five countries) or stabilized (35 countries), after increasing for many years; in contrast, rates continued to increase for four countries in Eastern Europe and Asia.
Prostate cancer remains the second most common cancer among men. Screening is gaining acceptance, likely reducing mortality at the cost of overdiagnosis and overtreatment. Increasing use of magnetic resonance imaging and biomarkers may mitigate some of the negative consequences of screening.
